# Hospital Universitario La Paz

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/hospital-universitario-la-paz/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 50.8 |
| Citations | 1,578,495 |
| City | Madrid |
| Country | ES |
| Description | Hospital Universitario La Paz is a research organisation in Madrid, ES. OpenAlex records 33,897 works and 1,578,495 citations for it. 10,365 researchers list it as their most recent affiliation. |
| Homepage | http://hulp.es/ |
| OpenAlex ID | https://openalex.org/I2800562746 |
| Region | Madrid |
| Researchers | 10,365 |
| ROR ID | https://ror.org/01s1q0w69 |
| Type | healthcare |
| Works | 33,897 |

## University papers

Showing 12 of 54.

- [A New Equation to Estimate Glomerular Filtration Rate](https://scholariq.org/papers/a-new-equation-to-estimate-glomerular-filtration-rate/)
- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction](https://scholariq.org/papers/efficacy-and-safety-of-low-dose-colchicine-after-myocardial-infarction/)
- [Treating rheumatoid arthritis to target: recommendations of an international task force](https://scholariq.org/papers/treating-rheumatoid-arthritis-to-target-recommendations-of-an-international-task/)
- [\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.](https://scholariq.org/papers/neular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force](https://scholariq.org/papers/treating-rheumatoid-arthritis-to-target-2014-update-of-the-recommendations-of-an/)
- [Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial](https://scholariq.org/papers/long-term-management-of-moderate-to-severe-atopic-dermatitis-with-dupilumab-and/)
- [American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials](https://scholariq.org/papers/american-college-of-rheumatology-european-league-against-rheumatism-provisional/)
- [Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome](https://scholariq.org/papers/apixaban-with-antiplatelet-therapy-after-acute-coronary-syndrome/)
- [Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery](https://scholariq.org/papers/guidelines-for-pre-operative-cardiac-risk-assessment-and-perioperative-cardiac-2/)
- [Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*](https://scholariq.org/papers/tralokinumab-for-moderate-to-severe-atopic-dermatitis-results-from-two-52-week/)
- [Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial](https://scholariq.org/papers/efficacy-of-apixaban-when-compared-with-warfarin-in-relation-to-renal-function/)

## University researchers

- [Pedro Herranz](https://scholariq.org/researchers/pedro-herranz/)
- [Esther Ramos Boluda](https://scholariq.org/researchers/esther-ramos-boluda/)
- [Samara Palma Milla](https://scholariq.org/researchers/samara-palma-milla/)
- [Maria Fernandez Nieto](https://scholariq.org/researchers/maria-fernandez-nieto/)

## University top topics

Showing 8 of 25.

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Congenital Heart Disease Studies](https://scholariq.org/topics/congenital-heart-disease-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.